0001192482-20-000121.txt : 20200205 0001192482-20-000121.hdr.sgml : 20200205 20200205162138 ACCESSION NUMBER: 0001192482-20-000121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200203 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bayley Matthew D CENTRAL INDEX KEY: 0001723040 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35112 FILM NUMBER: 20579024 MAIL ADDRESS: STREET 1: C/O AEVI GENOMIC MEDICINE, INC. STREET 2: 435 DEVON PARK DR., SUITE 715 CITY: WAYNE STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aevi Genomic Medicine, Inc. CENTRAL INDEX KEY: 0001138776 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 980217544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 435 DEVON PARK DRIVE, STREET 2: SUITE 715 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 610-254-4201 MAIL ADDRESS: STREET 1: 435 DEVON PARK DRIVE, STREET 2: SUITE 715 CITY: WAYNE STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: MEDGENICS, INC. DATE OF NAME CHANGE: 20090623 FORMER COMPANY: FORMER CONFORMED NAME: MEDGENICS INC DATE OF NAME CHANGE: 20010419 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-02-03 1 0001138776 Aevi Genomic Medicine, Inc. GNMX 0001723040 Bayley Matthew D C/O AEVI GENOMIC MEDICINE, INC. 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 1 0 0 0 Stock Option (Right to Purchase) 1.25 2020-02-03 4 D 0 40000 0 D 2027-12-04 Common Stock 40000 0 D Stock Option (Right to Purchase) 1.55 2020-02-03 4 D 0 50000 0 D 2028-04-17 Common Stock 50000 0 D This option, which became exercisable on December 4, 2018, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the previously announced Agreement and Plan of Merger and Reorganization by and among Cerecor Inc. ("Cerecor"), Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and issuer (the "Merger"). This option, which became exercisable on April 17, 2019, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger. /s/ Matthew D. Bayley 2020-02-05